Insmed Incorporated · 12 hours ago
Associate Scientist, Biology (R)
Joint Training and Training Development Center, NJ
Full-time
Onsite
Mid, Senior Level
$103K/yr - $131K/yr
2+ years expInsmed Incorporated is a global biopharmaceutical company focused on transforming the lives of patients with serious and rare diseases. The In vivo Associate Scientist, Biology will support early-stage research by executing in vivo pharmacology studies, developing custom animal models, and generating high-quality data.
BiotechnologyMedicalPharmaceutical
Responsibilities
Administer therapeutic agents to rodents through a variety of routes (including intraperitoneal, intravenous, oral, retroorbital, intrathecal, intratracheal, subcutaneous, intracerebroventricular)
Perform blood collection through various routes (including submandibular, saphenous vein, tail vein, cardiac puncture)
Perform necropsy, tissue collections, and perfusions
Monitor animal health, record clinical observations, and maintain accurate study records
Assist in developing, optimizing, and validating rodent disease models
Collaborate closely with in vivo team members, vivarium staff, internal project leads, and ex vivo analysis teams
Author and review protocols and electronic notebook entries
Analyze and present data to project teams
Follow institutionally approved animal protocols, IACUC guidelines, and adhere to all ethical, regulatory, and safety standards in an AAALAC accredited environment
Qualification
Required
Minimum of Bachelor's degree in biology, animal sciences, pharmacology or related field with 5+ years of relevant industry experience or Master's degree with 2+ years of industry experience
At least 2-5 years of prior experience with hands on in vivo research including work with rodents
Expert knowledge in standard rodent in vivo techniques (dosing, handling, restraint, sample collection)
Comprehensive experience in standard fluid collection techniques including tail vein and saphenous vein
At least 2 years of prior experience with and demonstrated excellence in tissue collection and animal necropsy
At least 2 years of prior experience with and demonstrated success in executing in vivo studies
At least 2 years of prior experience with and demonstrated success in assisting with developing custom animal models suitable for a variety of disease applications
Experience with breeding and maintenance of genetically modified mouse strains
Strong attention to detail, excellent record keeping (E-note booking), and the ability to follow SOP's and protocols
Entrepreneurial spirit, proactive problem-solving attitude, and strong willingness to take on new challenges
Benefits
Comprehensive medical, dental, and vision coverage and mental health support, annual wellbeing reimbursement, and access to our Employee Assistance Program (EAP)
Generous paid time off policies, fertility and family-forming benefits, caregiver support, and flexible work schedules with purposeful in-person collaboration
401(k) plan with a competitive company match, annual equity awards, and participation in our Employee Stock Purchase Plan (ESPP), and company-paid life and disability insurance
Company Learning Institute providing access to LinkedIn Learning, skill building workshops, leadership programs, mentorship connections, and networking opportunities
Employee resource groups, service and recognition programs, and meaningful opportunities to connect, volunteer, and give back
Company
Insmed Incorporated
Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases.
1001-5000 employees
H1B Sponsorship
Insmed Incorporated has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (20)
2024 (6)
2023 (14)
2022 (8)
2021 (1)
2020 (5)
Funding
Current Stage
Public CompanyTotal Funding
$4.56BKey Investors
CureDuchenne Ventures
2025-06-11Post Ipo Equity· $750M
2024-05-30Post Ipo Equity· $650M
2023-05-08Post Ipo Equity· $0.5M
Leadership Team
Will Lewis
Chairman and Chief Executive officer
Walter R. Perkins
Chief Technology Officer
Recent News
2026-01-13
2026-01-11
Company data provided by crunchbase